NCT05332262View on ClinicalTrials.gov

A Precision Medicine Approach to Identify Patients Undergoing Elective PCI at Risk of Peri-PCI Myocardial Infarction

RecruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

May 23, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

August 31, 2026

Conditions
Coronary Artery Disease
Interventions
DIAGNOSTIC_TEST

Assessment of platelet reactivity

Assessment of platelet reactivity and HPR status will be performed post-PCI. Platelet reactivity will be measured by VerifyNow P2Y12 and HPR status will be defined using a cut-off value of platelet reactivity units (PRU)\>208.

DIAGNOSTIC_TEST

Troponin measurement

Measurement of high sensitivity troponin for the assessment for the presence of myocardial infarction/myocardial injury will be performed post-PCI.

Trial Locations (1)

32209

RECRUITING

University of Florida Jacksonville, Jacksonville

All Listed Sponsors
lead

University of Florida

OTHER